Organized, biennial fecal immunochemical testing-based screening linked to lower colorectal cancer mortality
AI Summary
A study published in JAMA Network Open found that organized, biennial fecal immunochemical testing-based screening leads to reduced colorectal cancer mortality. This highlights the importance of regular screening programs for early cancer detection and prevention.
An organized fecal immunochemical testing (FIT)-based colorectal cancer (CRC) screening program is associated with a sustained decline in CRC mortality, according to a study published online Aug. 5 in JAMA Network Open.
Health colorectal cancer screening fecal immunochemical test mortality reduction JAMA Network Open public health